7-CHLORO-2-(METHYLAMINO)-3H-1,4-BENZODIAZEPIN-5-YL DI(4-MORPHOLINYL)PHOSPHINATE
UNII KCN8HH75GH
Substance Identification & Data
This profile provides standardized clinical and technical data for 7-chloro-2-(methylamino)-3h-1,4-benzodiazepin-5-yl Di(4-morpholinyl)phosphinate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) KCN8HH75GH.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 59318-14-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C18H25ClN5O4P LJICIVONMGJXQV-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 7-chloro-2-(methylamino)-3h-1,4-benzodiazepin-5-yl Di(4-morpholinyl)phosphinate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.